ADAMTS13 and thrombotic thrombocytopenic purpura: Measuring ADAMTS13 activity aids in differentiating PE from other TMAs, such as thrombotic thrombocytopenic purpura (TTP) and hemolytic–uremic syndrome (HUS), and provides insight into endothelial dysfunction, prognosis, and therapeutic decision-making [51].